In today’s podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes.

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
In today’s podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes.
On today’s podcast and Cushing’s awareness day and month, we bring you a few excerpts from our soon-to-be-released new book on Cushing’s. The book’s author and Pituitary World News cofounder, Dr. Lewis Blevins, reads from a few selected chapters to give insight into the book’s content.
Today’s podcast is about our super athlete friend Risa August and her new book about her acromegaly experience, her life, and her 1,800 mile ride from Canada to Mexico.
Spain and Spanish-speaking countries have been our focus as we seek to develop more content in Spanish for our edition of Pituitary Word News in Español. Today’s podcasts covers part of the conference and shares my conversations with three world-renowned Spanish endocrinologists.
In today’s podcast, we talk with Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, where he leads a team in developing and marketing treatments for rare and ultra-rare diseases.
In today’s podcast, Veronica, an MBA graduate of Notre Dame University and law school student, tells us about her experience with a prolactinoma. What is interesting about this story is that in pituitary medicine, where delays in diagnosis and general unawareness are all too often the order of the day, this is a perfect example of how awareness and smart thinking make things work as they are supposed to.
Podcast and Video: In today’s podcast and accompanying video, Dr. Blevins discusses and illustrates the case of a patient with a double pituitary adenoma.
Today, Dr. Scott Struthers talks to PWN about paltusotine, their new once-a-day oral drug candidate, which recently completed phase 3 of the clinical trial.
Today, I am particularly thrilled about this podcast with a group of leading professional nurses who are educators, scientists, researchers, nurse practitioners, and graduate students.
Listen to this podcast and learn more about this new groundbreaking educational program exclusively produced by Pituitary World News.
Noncompliance with required follow-up visits and properly taking medications is a serious issue. Dr. Blevins tackles this problem with real clinical examples in this brief podcast.
From the PWN library, we highlight our engaging podcast series “Musings,” covering various exciting subjects directly from Dr. Blevins’ desk. From lab result targets explaining how lab tests work, to what makes aiming at and